AMERICAN JOURNAL OF HYPERTENSION
Scope & Guideline
Transforming hypertension knowledge into practice.
Introduction
Aims and Scopes
- Clinical Research and Trials:
The journal emphasizes original clinical research and randomized controlled trials that provide evidence-based insights into hypertension management and treatment efficacy. - Pathophysiological Mechanisms:
Investigations into the biological and physiological mechanisms underlying hypertension, including studies on vascular function, renal mechanisms, and hormonal influences. - Epidemiology and Public Health:
Research on the prevalence, risk factors, and socio-economic determinants of hypertension, aiming to inform public health strategies and interventions. - Innovative Treatment Approaches:
Exploration of novel pharmacological and non-pharmacological treatment options for hypertension, including lifestyle modifications and new drug classes. - Technological Advancements:
Integration of technology in hypertension management, such as telemonitoring, mobile health applications, and wearable devices for blood pressure monitoring. - Health Disparities:
Focus on understanding and addressing racial, ethnic, and socio-economic disparities in hypertension prevalence and management.
Trending and Emerging
- Multifactorial Approaches to Hypertension Management:
An increasing number of studies focus on the interplay of genetic, environmental, and lifestyle factors in hypertension, emphasizing a multifaceted approach to treatment. - Impact of Social Determinants of Health:
Research highlighting the influence of social determinants, such as socioeconomic status and access to care, on hypertension outcomes is becoming more prominent. - Hypertension in Special Populations:
Emerging studies are focusing on hypertension in specific populations, including pregnant women, children, and ethnic minorities, addressing unique challenges and treatment responses. - Technological Integration in Hypertension Care:
There is a growing interest in the use of digital health technologies, such as telehealth and mobile health applications, to enhance hypertension management and patient engagement. - Comorbidities and Hypertension:
The relationship between hypertension and other chronic conditions, such as diabetes and cardiovascular diseases, is increasingly being explored, emphasizing comprehensive patient management. - Patient-Centered Care and Experiences:
Research focusing on patient experiences, preferences, and adherence to hypertension treatment is gaining traction, reflecting a shift towards more personalized care.
Declining or Waning
- Traditional Pharmacological Approaches:
There has been a noticeable decrease in studies solely focusing on traditional antihypertensive medications, as newer treatment strategies and combination therapies gain attention. - Static Risk Factor Analysis:
Research that solely addresses static risk factors for hypertension, such as age and BMI, is becoming less common, with a shift toward more dynamic and multifactorial approaches. - Basic Science Studies:
There is a waning interest in purely basic science research without direct clinical implications, as the journal increasingly prioritizes translational and clinical research. - Longitudinal Cohort Studies:
Although still valuable, there appears to be a decrease in the publication of large longitudinal cohort studies that focus solely on hypertension without incorporating intervention strategies.
Similar Journals
REVISTA ESPANOLA DE CARDIOLOGIA
Transforming Cardiovascular Research into Real-World ImpactREVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.
Nature Reviews Cardiology
Navigating the Complexities of Cardiovascular Health TogetherNature Reviews Cardiology, published by NATURE PORTFOLIO, stands as a premier academic journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and a distinguished ranking of #1 out of 387 in Scopus. Since its inception in 2009, this exemplary journal has continuously delivered cutting-edge reviews and insights, supporting researchers, healthcare professionals, and students in navigating the complex landscape of cardiovascular health. With a commitment to providing open access and disseminating rigorous research, Nature Reviews Cardiology captures the forefront of innovation and scholarship, critical for facilitating advancements in cardiovascular science and clinical practice. Situated in the United Kingdom and with a vibrant global readership, this journal perpetuates academic excellence, ensuring accessibility to the latest findings that shape prevention, diagnosis, and treatment strategies in cardiology through to 2024 and beyond.
JRSM Cardiovascular Disease
Bridging research and practice for a healthier heart.JRSM Cardiovascular Disease is a leading open-access journal published by SAGE Publications Ltd, dedicated to promoting research and knowledge dissemination in the vital field of cardiovascular health. Established in 2012, the journal plays a pivotal role in advancing the understanding of cardiovascular diseases through peer-reviewed articles, clinical studies, and innovative research findings. With a focus on enhancing patient care and public health, it aims to bridge the gap between research and practice, making it an essential resource for researchers, healthcare professionals, and students alike. By facilitating open access to its content, JRSM Cardiovascular Disease ensures that significant discoveries and advancements are available to a global audience, thereby contributing to the ongoing dialogue and collaboration within the cardiovascular disease community. This journal not only highlights critical advancements but also fosters an environment for continuous education and improvement in the field.
Advances in Rheumatology
Fostering collaboration for cutting-edge rheumatological advancements.Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.
CURRENT HYPERTENSION REPORTS
Empowering professionals with cutting-edge insights.CURRENT HYPERTENSION REPORTS is a premier journal dedicated to advancing the field of cardiovascular health, particularly focusing on hypertension and its multifaceted implications. Published by SPRINGER, this influential journal boasts an impressive impact factor and ranks in the top Q1 category among Internal Medicine journals, placing it within the elite 88th percentile of its field according to Scopus rankings. Since its inception in 1999, it has provided a platform for cutting-edge research and clinical insights, facilitating knowledge exchange among researchers, healthcare professionals, and students alike. With a commitment to publishing high-quality articles without open access barriers, CURRENT HYPERTENSION REPORTS remains an essential resource for those looking to stay abreast of the latest developments and trends in hypertension management and treatment.
SCHIZOPHRENIA BULLETIN
Unraveling the mysteries of schizophrenia since 1973.SCHIZOPHRENIA BULLETIN, published by Oxford University Press, stands as a leading journal in the field of psychiatry and mental health, particularly focusing on the complexities of schizophrenia. Established in 1973, this esteemed journal covers a wide spectrum of research areas, including clinical findings, neurobiology, epidemiology, and treatment approaches, making it indispensable for researchers and practitioners alike. With its current status in the Q1 category of the psychiatry and mental health disciplines, and a remarkable Scopus rank of #34 out of 567, the journal enjoys a strong impact factor, emphasizing its contribution to advancing knowledge in mental health. Although it operates on a subscription model, the significance of the journal in disseminating groundbreaking research makes it a vital resource for those committed to improving outcomes in schizophrenia. Through its rigorous peer-review process and commitment to high-quality scientific communication, SCHIZOPHRENIA BULLETIN continues to be at the forefront of psychiatric research and discourse.
Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
Pioneering Research for a Healthier Future in Women's Cardiovascular CarePregnancy Hypertension – An International Journal of Women's Cardiovascular Health, published by Elsevier Science Ltd, is a leading platform dedicated to advancing the understanding of cardiovascular health in women during pregnancy and postpartum periods. With an ISSN of 2210-7789, this esteemed journal has distinguished itself in the fields of Internal Medicine and Obstetrics and Gynecology, maintaining a remarkable Q2 ranking in Internal Medicine and a prestigious Q1 ranking in Obstetrics and Gynecology as of 2023. It is recognized for its high-quality research, which fits within the top quartile of its categories, and spans from 2010 to 2024, reflecting its ongoing contribution to critical advancements in women's cardiovascular health. The journal is accessible to a global audience of researchers, practitioners, and students, emphasizing its commitment to promoting open scholarly communication, although it currently operates under traditional access. The publication serves as a crucial resource for those seeking to enhance their knowledge and practices related to the unique cardiovascular challenges faced by women during pregnancy, thereby fostering informed clinical approaches and improved health outcomes.
Russian Open Medical Journal
Pioneering research for a brighter future in healthcare.Russian Open Medical Journal is an esteemed academic publication launched in 2012 by SCIENCE & INNOVATION, LTD, dedicated to advancing the field of medicine and promoting innovative research. As an Open Access journal, it ensures that knowledge is freely accessible to all, fostering collaboration and dissemination of vital medical findings. Based in the Russian Federation, this journal covers a wide array of topics under the domain of general medicine and contributes to the global medical discourse with its commitment to quality research dissemination. With a current Scopus rank of #368 out of 636 in the category of General Medicine, placing it in the 42nd percentile, the journal demonstrates a growing impact within the scientific community. Researchers, healthcare professionals, and students seeking to explore contemporary medical issues will find this journal a valuable resource, reflecting a global perspective while emphasizing innovative solutions to health challenges.
KIDNEY & BLOOD PRESSURE RESEARCH
Connecting Researchers to Combat Kidney and Blood Pressure Challenges.Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.
BLOOD PRESSURE
Exploring the dynamics of blood pressure for better patient outcomes.BLOOD PRESSURE is a distinguished journal published by Taylor & Francis Ltd in the field of cardiology and internal medicine, with an ISSN of 0803-7051 and E-ISSN of 1651-1999. Since its inception in 1992, it has become a vital source of research and clinical information, dedicated to advancing our understanding of blood pressure-related health issues. With a notable categorization of Q3 in Cardiology and Cardiovascular Medicine and Q2 in Internal Medicine as of 2023, this journal exemplifies a commitment to evidence-based findings that impact clinical practice and patient care. The journal facilitates a platform for original research, reviews, and case studies, aiming to bridge the gap between researchers and practitioners. Although it does not currently offer open access, BLOOD PRESSURE remains an essential resource for professionals and students alike, striving to enhance health outcomes through dedication to innovative cardiovascular research.